SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-019540
Filing Date
2024-03-04
Accepted
2024-03-04 16:05:59
Documents
14
Period of Report
2024-02-28
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0201126-8k_allarity.htm   iXBRL 8-K 30362
  Complete submission text file 0001213900-24-019540.txt   204366

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE allr-20240228.xsd EX-101.SCH 3015
3 XBRL LABEL FILE allr-20240228_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE allr-20240228_pre.xml EX-101.PRE 22359
15 EXTRACTED XBRL INSTANCE DOCUMENT ea0201126-8k_allarity_htm.xml XML 3774
Mailing Address 24 SCHOOL ST., 2ND FLOOR BOSTON MA 02108
Business Address 24 SCHOOL ST., 2ND FLOOR BOSTON MA 02108 401-426-4664
Allarity Therapeutics, Inc. (Filer) CIK: 0001860657 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41160 | Film No.: 24714989
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)